High expression of Foxp3, IL-23p19 and survivin mRNA in colorectal carcinoma

被引:26
作者
Stanilov, Noyko [2 ]
Miteva, Lyuba [1 ]
Mintchev, Nikolay [1 ]
Stanilova, Spaska [1 ]
机构
[1] Trakia Univ, Fac Med, Dept Mol Biol Immunol & Genet, Stara Zagora 6000, Bulgaria
[2] Trakia Univ, Fac Med, Univ Hosp, Surg Clin 2,Dept Neurosurg Surg & Urol, Stara Zagora 6000, Bulgaria
关键词
Colorectal carcinoma; Cytokine; qRT-PCR; IL-12p40; IL-23; REGULATORY T-CELLS; FACTOR-KAPPA-B; COLON-CARCINOMA; CYTOKINE EXPRESSION; ANTITUMOR IMMUNITY; GENE-EXPRESSION; CANCER; TUMOR; INTERLEUKIN-12; INFLAMMATION;
D O I
10.1007/s00384-008-0588-8
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Cytokines have been suggested to both modulate anti-tumor responses and promote tumor growth. We analyzed the expression of pro-inflammatory IL-12p35, IL-12p40, IL-23p19, anti-inflammatory IL-10, antiapoptotic factor survivin, and transcription factors-RelA, c-Jun, and Foxp3 mRNA in patients' blood, colon carcinoma tissue, and in normal mucosal tissue by real-time polymerase chain reaction. The quantity determination of serum IL-12p40, IL-23, and IL-10 was performed by enzyme-linked immunosorbent assay. We observed significantly higher levels in patients for all three analyzed cytokines, with IL-23 concentration change being the highest. We detected the greatest upregulation of IL-23p19, Foxp3 and survivin mRNA in colorectal carcinomas than normal mucosa. A statistically significant upregulation of IL-12p40, IL-10, and c-Jun mRNA but not for IL-12p35 and RelA mRNA in tumor tissue comparing to normal tissue was also established. In conclusion, we show a characteristic gene expression profile combining markers associated with inhibition of anti-tumor immune response (Foxp3, IL-10), inhibition of apoptosis (survivin), and induction of the cytokines with protumoral activity as IL-12p40 and IL-23p19 (IL-23) in the colorectal tumor tissue but not in peripheral blood of patients.
引用
收藏
页码:151 / 157
页数:7
相关论文
共 35 条
[21]   Secretion of interleukin-10 from murine colon carcinoma cells suppresses systemic antitumor immunity and impairs protective immunity induced against the tumors [J].
Kawamura K. ;
Bahar R. ;
Natsume W. ;
Sakiyama S. ;
Tagawa M. .
Cancer Gene Therapy, 2002, 9 (1) :109-115
[22]   IL-23 promotes tumour incidence and growth [J].
Langowski, John L. ;
Zhang, Xueqing ;
Wu, Lingling ;
Mattson, Jeanine D. ;
Chen, Taiying ;
Smith, Kathy ;
Basham, Beth ;
McClanahan, Terrill ;
Kastelein, Robert A. ;
Oft, Martin .
NATURE, 2006, 442 (7101) :461-465
[23]   High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas [J].
Le Gouvello, S. ;
Bastuji-Garin, S. ;
Aloulou, N. ;
Mansour, H. ;
Chaumette, M-T ;
Berrehar, F. ;
Seikour, A. ;
Charachon, A. ;
Karoui, M. ;
Leroy, K. ;
Farcet, J-P ;
Sobhani, I. .
GUT, 2008, 57 (06) :772-779
[24]  
LING P, 1995, J IMMUNOL, V154, P116
[25]   Antitumor and antimetastatic activity of IL-23 [J].
Lo, CH ;
Lee, SC ;
Wu, PY ;
Pan, WY ;
Su, J ;
Cheng, CW ;
Roffler, SR ;
Chiang, BL ;
Lee, CN ;
Wu, CW ;
Tao, MH .
JOURNAL OF IMMUNOLOGY, 2003, 171 (02) :600-607
[26]  
MURPHY TL, 1995, MOL CELL BIOL, V15, P5258
[27]  
O'Hara RJ, 1998, CLIN CANCER RES, V4, P1943
[28]  
Shan BE, 2006, CELL MOL IMMUNOL, V3, P47
[29]   Induction of systemic immunity by expression of interleukin-23 in murine colon carcinoma cells [J].
Wang, YQ ;
Ugai, S ;
Shimozato, O ;
Yu, L ;
Kawamura, K ;
Yamamoto, H ;
Yamaguchi, T ;
Saisho, H ;
Tagawa, M .
INTERNATIONAL JOURNAL OF CANCER, 2003, 105 (06) :820-824
[30]   Regulation of IL-10 gene expression in Th2 cells by Jun proteins [J].
Wang, ZY ;
Sato, H ;
Kusam, S ;
Sehra, S ;
Toney, LM ;
Dent, AL .
JOURNAL OF IMMUNOLOGY, 2005, 174 (04) :2098-2105